Cargando…
Management of idiopathic epistaxis in adults: what’s new?
Epistaxis is one of the most common complaints presenting to emergency departments. The aim of this study is to systematically review and critically evaluate the evidence relating to treatment of idiopathic epistaxis for guiding best practice. A comprehensive review of the English language literatur...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Pacini Editore Srl
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6734206/ https://www.ncbi.nlm.nih.gov/pubmed/30933179 http://dx.doi.org/10.14639/0392-100X-2155 |
_version_ | 1783450103052238848 |
---|---|
author | MECCARIELLO, G. GEORGALAS, C. MONTEVECCHI, F. CAMMAROTO, G. GOBBI, R. FIRINU, E. DE VITO, A. VICINI, C. |
author_facet | MECCARIELLO, G. GEORGALAS, C. MONTEVECCHI, F. CAMMAROTO, G. GOBBI, R. FIRINU, E. DE VITO, A. VICINI, C. |
author_sort | MECCARIELLO, G. |
collection | PubMed |
description | Epistaxis is one of the most common complaints presenting to emergency departments. The aim of this study is to systematically review and critically evaluate the evidence relating to treatment of idiopathic epistaxis for guiding best practice. A comprehensive review of the English language literature was performed using PubMed, Embase, Cochrane Library and Central electronic databases. The inclusion criteria were: retrospective or prospective or randomised controlled clinical trials which included outcomes in the management of idiopathic epistaxis. Twenty-three articles met inclusion criteria and were reviewed. Nasal packing still represents the first-line approach to epistaxis, although, at present, it appears that there is clear evidence in the literature to suggest that it is less effective and associated with more admissions and longer hospital stays than endoscopic electrocoagulation-based management of epistaxis. In conclusion, cauterisation should be the first-line approach for its high cost-effectiveness rate and low risk of complications. Further research is urgently needed to assess the efficacy of new biomaterials. |
format | Online Article Text |
id | pubmed-6734206 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Pacini Editore Srl |
record_format | MEDLINE/PubMed |
spelling | pubmed-67342062019-09-14 Management of idiopathic epistaxis in adults: what’s new? MECCARIELLO, G. GEORGALAS, C. MONTEVECCHI, F. CAMMAROTO, G. GOBBI, R. FIRINU, E. DE VITO, A. VICINI, C. Acta Otorhinolaryngol Ital Review Epistaxis is one of the most common complaints presenting to emergency departments. The aim of this study is to systematically review and critically evaluate the evidence relating to treatment of idiopathic epistaxis for guiding best practice. A comprehensive review of the English language literature was performed using PubMed, Embase, Cochrane Library and Central electronic databases. The inclusion criteria were: retrospective or prospective or randomised controlled clinical trials which included outcomes in the management of idiopathic epistaxis. Twenty-three articles met inclusion criteria and were reviewed. Nasal packing still represents the first-line approach to epistaxis, although, at present, it appears that there is clear evidence in the literature to suggest that it is less effective and associated with more admissions and longer hospital stays than endoscopic electrocoagulation-based management of epistaxis. In conclusion, cauterisation should be the first-line approach for its high cost-effectiveness rate and low risk of complications. Further research is urgently needed to assess the efficacy of new biomaterials. Pacini Editore Srl 2019-08 2019-03-25 /pmc/articles/PMC6734206/ /pubmed/30933179 http://dx.doi.org/10.14639/0392-100X-2155 Text en Società Italiana di Otorinolaringoiatria e Chirurgia Cervico-Facciale, Rome, Italy http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0), which permits for noncommercial use, distribution, and reproduction in any digital medium, provided the original work is properly cited and is not altered in any way. For details, please refer to https://creativecommons.org/licenses/by-nc-nd/4.0/ |
spellingShingle | Review MECCARIELLO, G. GEORGALAS, C. MONTEVECCHI, F. CAMMAROTO, G. GOBBI, R. FIRINU, E. DE VITO, A. VICINI, C. Management of idiopathic epistaxis in adults: what’s new? |
title | Management of idiopathic epistaxis in adults: what’s new? |
title_full | Management of idiopathic epistaxis in adults: what’s new? |
title_fullStr | Management of idiopathic epistaxis in adults: what’s new? |
title_full_unstemmed | Management of idiopathic epistaxis in adults: what’s new? |
title_short | Management of idiopathic epistaxis in adults: what’s new? |
title_sort | management of idiopathic epistaxis in adults: what’s new? |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6734206/ https://www.ncbi.nlm.nih.gov/pubmed/30933179 http://dx.doi.org/10.14639/0392-100X-2155 |
work_keys_str_mv | AT meccariellog managementofidiopathicepistaxisinadultswhatsnew AT georgalasc managementofidiopathicepistaxisinadultswhatsnew AT montevecchif managementofidiopathicepistaxisinadultswhatsnew AT cammarotog managementofidiopathicepistaxisinadultswhatsnew AT gobbir managementofidiopathicepistaxisinadultswhatsnew AT firinue managementofidiopathicepistaxisinadultswhatsnew AT devitoa managementofidiopathicepistaxisinadultswhatsnew AT vicinic managementofidiopathicepistaxisinadultswhatsnew |